Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beat Mueller

Showing results (1-10 of 299) with videos related to

Pageof 30
Sort By:
Annals of Emergency Medicine|August 26, 2015
Procalcitonin: An Effective Screening Tool and Safe Therapeutic Decisionmaking Aid for Emergency Department Patients With Suspected SepsisPhilipp Schuetz, Beat Mueller
Expert Review of Clinical Immunology|July 30, 2014
The role of immune and metabolic biomarkers for improved management of sepsis patientsPhilipp Schuetz, Beat Mueller
Critical Care Medicine|February 22, 2013
It Is all about risk-adapted algorithmsPhilipp Schuetz, Beat Mueller
Lancet (London, England)|July 17, 2017
Procalcitonin-guided antibiotic stewardship from newborns to centennialsPhilipp Schuetz, Beat Mueller
JAMA|July 26, 2018
Procalcitonin to Guide Antibiotic Decisions-ReplyPhilipp Schuetz, Beat Mueller
Critical Care Medicine|October 19, 2011
To escalate or to de-escalte--that is the questionPhilipp Schuetz, Beat Mueller
Intensive Care Medicine|October 31, 2013
Biomarker-guided de-escalation of empirical therapy is associated with lower risk for adverse outcomesPhilipp Schuetz, Beat Mueller
Expert Review of Anti-Infective Therapy|June 23, 2011
Predicting bacteremia by procalcitonin levels in patients evaluated for sepsis in the emergency departmentWerner C Albrich, Beat Mueller
Current Opinion in Critical Care|May 22, 2012
Do sepsis biomarkers in the emergency room allow transition from bundled sepsis care to personalized patient care?Philipp Schuetz, Sebastian Haubitz, Beat Mueller
JAMA|March 7, 2018
Procalcitonin Testing to Guide Antibiotic Therapy in Acute Upper and Lower Respiratory Tract InfectionsPhilipp Schuetz, Yannick Wirz, Beat Mueller
Pageof 30

Showing results (1-10 of 299) with videos related to

Sort By:
Pageof 30
Annals of Emergency Medicine|August 26, 2015
Procalcitonin: An Effective Screening Tool and Safe Therapeutic Decisionmaking Aid for Emergency Department Patients With Suspected SepsisPhilipp Schuetz, Beat Mueller
Expert Review of Clinical Immunology|July 30, 2014
The role of immune and metabolic biomarkers for improved management of sepsis patientsPhilipp Schuetz, Beat Mueller
Critical Care Medicine|February 22, 2013
It Is all about risk-adapted algorithmsPhilipp Schuetz, Beat Mueller
Lancet (London, England)|July 17, 2017
Procalcitonin-guided antibiotic stewardship from newborns to centennialsPhilipp Schuetz, Beat Mueller
JAMA|July 26, 2018
Procalcitonin to Guide Antibiotic Decisions-ReplyPhilipp Schuetz, Beat Mueller
Critical Care Medicine|October 19, 2011
To escalate or to de-escalte--that is the questionPhilipp Schuetz, Beat Mueller
Intensive Care Medicine|October 31, 2013
Biomarker-guided de-escalation of empirical therapy is associated with lower risk for adverse outcomesPhilipp Schuetz, Beat Mueller
Expert Review of Anti-Infective Therapy|June 23, 2011
Predicting bacteremia by procalcitonin levels in patients evaluated for sepsis in the emergency departmentWerner C Albrich, Beat Mueller
Current Opinion in Critical Care|May 22, 2012
Do sepsis biomarkers in the emergency room allow transition from bundled sepsis care to personalized patient care?Philipp Schuetz, Sebastian Haubitz, Beat Mueller
JAMA|March 7, 2018
Procalcitonin Testing to Guide Antibiotic Therapy in Acute Upper and Lower Respiratory Tract InfectionsPhilipp Schuetz, Yannick Wirz, Beat Mueller
Pageof 30